Next stop, Milan - Welcome to Italy's life sciences hub
Milan is home to an internationally competitive pharmaceutical, biotechnology and functional foods hub, with strong growth prospects and a commitment to innovation across its entire supply chain. Italy is also home to one of the most advanced and efficient healthcare systems in Europe - making it an exciting destination for the 2021 CPHI Worldwide event.
CPHI Worldwide is back
From 9-11 November 2021, CPHI Worldwide will take place in Milan, Italy, after a two-year, COVID-19 induced break.
This year, the event is going hybrid, with an online platform open four weeks prior to the in-person event for matchmaking, networking and meetings. There is also a online content programme of 50+ sessions being broadcast from 25 October onwards - giving attendees all the insights they need to prepare for both virtual and on-site meetings in Milan.
The world's largest pharmaceutical gathering was last held in Lombardy's capital in 2007, so this year marks a long-awaited return not only to the in-person experience of CPHI Worldwide, but also to the epicentre of the Italian pharmaceutical industry.
What makes Milan such an exciting destination for pharma?
Learn more about Milan's ecosystem for life sciences
Did you know that the Greater Milano Region generates 33% of the Italian registered patents in the EU and supplies 5% of the world's active ingredients? Local Life Sciences production is worth €71 billion and employs 356,000 people.
For more information, take a look at Yes Milano's comprehensive report on Milan's life sciences ecosystem, including the innovation district, research excellence, talent development and manufacturing expertise.
You can also hear directly from Milano&Partners at the CPHI Worldwide online content programme, join us on 25 October to explore macro data and regional successes. If you have not yet registered for the CPHI Worldwide hybrid event, there is still time, whether you;re joining us in-person or online.
Register for CPHI Worldwide now
Planning to join us in Milan?
If you'll be visiting CPHI Worldwide in Milan this year, there are several useful resources on the CPHI Worldwide website covering visa applications, COVID-19 measures, accommodation and the Informa AllSecure commitments for a safe and enjoyable event experience.
Prepare for your trip to Milan
Ci vediamo lì!
Related News
-
News How to disrupt an industry as big as pharma for the better?
In this interview, hear from Matthew Wise, Head of Data at CCD Partners, on the companies they've been looking into that are offering new and interesting perspectives that have the potential to shake up the pharmaceutical industry, and how they'... -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance